Q4 2025 Holdings
Filed 2026-02-17 | 100 holdings | $517.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $35.1M | 1,123,525 | 6.8% |
| Biogen Inc(BIIB) | COM | 09062X103 | $16.7M | 94,738 | 3.2% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $16.3M | 449,003 | 3.1% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $16.0M | 762,563 | 3.1% |
| Nova LTD(NVMI) | COM | M7516K103 | $15.7M | 47,846 | 3.0% |
| Tower Semiconductor LTD(TSEM) | SHS NEW | M87915274 | $14.4M | 122,513 | 2.8% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $13.4M | 378,500 | 2.6% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $12.4M | 135,060 | 2.4% |
| Praxis Precision Medicines I(PRAX)Call | COM NEW | 74006W207 | $11.8M | 40,000 | 2.3% |
| Sanofi SA(SNY) | SPONSORED ADR | 80105N105 | $11.6M | 239,515 | 2.2% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $9.7M | 9,040 | 1.9% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $9.4M | 658,377 | 1.8% |
| Immatics N.v(IMTX) | SHS | N44445109 | $9.0M | 861,105 | 1.7% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $8.7M | 147,000 | 1.7% |
| Spdr Series Trust(XBI)Put | STATE STREET SPD | 78464A870 | $8.5M | 70,000 | 1.6% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $8.2M | 107,746 | 1.6% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $8.2M | 1,004,378 | 1.6% |
| Ultragenyx Pharmaceutical in(RARE)Call | COM | 90400D108 | $8.1M | 350,000 | 1.6% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $7.7M | 392,894 | 1.5% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $7.5M | 598,534 | 1.4% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $7.4M | 35,831 | 1.4% |
| Savara Inc(SVRA) | COM | 805111101 | $7.1M | 1,178,164 | 1.4% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $7.0M | 158,265 | 1.3% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $6.9M | 408,166 | 1.3% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $6.9M | 300,623 | 1.3% |
| Cybin Inc(HELP) | COM NEW | 23256X407 | $6.8M | 825,576 | 1.3% |
| Annexon Inc(ANNX) | COM | 03589W102 | $6.6M | 1,316,212 | 1.3% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $6.5M | 837,889 | 1.3% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $6.5M | 239,764 | 1.3% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $6.3M | 136,314 | 1.2% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $6.3M | 250,961 | 1.2% |
| Nice LTD(NSY)Call | SPONSORED ADR | 653656108 | $6.3M | 55,700 | 1.2% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $6.0M | 122,000 | 1.2% |
| Enphase Energy Inc(ENPH) | COM | 29355A107 | $6.0M | 186,500 | 1.2% |
| Novo-Nordisk A S(NVO) | ADR | 670100205 | $5.9M | 115,677 | 1.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $5.8M | 91,717 | 1.1% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $5.8M | 25,256 | 1.1% |
| Solaredge Technologies Inc(SEDG) | COM | 83417M104 | $5.7M | 196,536 | 1.1% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $5.7M | 212,202 | 1.1% |
| VOR Biopharma Inc(VOR) | COM NEW | 929033207 | $5.4M | 410,417 | 1.0% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $5.1M | 48,600 | 1.0% |
| Novartis AG(NVSN) | SPONSORED ADR | 66987V109 | $5.1M | 37,000 | 1.0% |
| Forte Biosciences Inc(FBRX) | COM NEW | 34962G208 | $5.1M | 185,869 | 1.0% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $4.9M | 175,500 | 0.9% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $4.8M | 544,563 | 0.9% |
| Solaredge Technologies Inc | NOTE 2.250% 7/0 | 83417MAE4 | $4.7M | 4,000,000 | 0.9% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $4.7M | 355,725 | 0.9% |
| Mediwound LTD(MDWD) | SHS NEW | M68830112 | $4.3M | 230,347 | 0.8% |
| Camtek LTD(CAMT) | ORD | M20791105 | $4.2M | 39,498 | 0.8% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $4.2M | 52,500 | 0.8% |